Experiment 1143549

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationKREIS,W: BUDMAN,DR: FREEMAN,J: GREIST,A: NELSON,RL: SCHULMAN,P: MARKS,M: KEVILL,L: VINCIGUERRA,V: DEGNAN,T:. (1984). CLINICAL PHARMACOLOGY STUDIES WIRTH ORALLY ADMINIISTERED 3-H-VINZOLIDINE.. ()
Amount utilized
Compound isolated
Disease3 CANCER PATIENTS WERE WITH TRITIATED DOSES OF 1.5, 29.2 AND 36.5 MG/SQ.M. ABSORPTION HALF TIME WAS 1.13 HRS. WITH A PEAK TIME OF 4 HRS. DECAY OF TOTAL TRITIUM IN THE PLASMA WAS BIPHASIC WITH INITIAL HALF LIFE OF 8.4 HRS. AND TERMINAL HALF LIFE OF 170 HRS. AFTER 2 WKS, 4% OF TOTAL RADIOACTIVITY WAS RECOVERED IN THE URINE AND 55% WAS RECOVERED IN THE FECES. ANALYSIS OF THE PLASMA AND URINE OF PATIENT 3 SHOWED A PREDOMINANCE OF UNCHANGED VINZOLIDINE.
Dose amount1.36 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE